NEW YORK, July 14, 2017 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit
has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Roche
Holding AG ("Roche Holding") (OTCMKTS:RHHBY) securities between March 2, 2017 and June 5,
2017.
Click here to learn about the case: http://www.wongesq.com/pslra-sa/roche-holding-ag?wire=3. There is no cost or obligation to
you.
According to the complaint, throughout the Class Period, the Company issued materially false and misleading
statements and/or failed to disclose that: (1) the combination of Perjeta and Herceptin is only marginally more effective than
Herceptin alone in preventing breast cancer; and (2) as a result, Defendants' statements about Roche Holding AG's business,
operations and prospects were materially false and misleading and/or lacked a reasonable bases at all relevant times.
If you suffered a loss in Roche Holding you have until August 7, 2017 to request that the Court
appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain
additional information, contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-sa/roche-holding-ag?wire=3.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving
financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar
outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: vw@wongesq.com
